Expression of beta 2-integrins and L-selectin on polymorphonuclear leukocytes in septic patients.
Expression of beta 2-integrins and L-selectin on polymorphonuclear leukocytes in septic patients.
复制标题
脓毒症患者多形核白细胞上β2-整合素和L-选择素的表达。
DOI:
10.1159/000129521
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Peter,K
中科院分区:
文献类型:
--
作者:
Thiel,M;Zourelidis,C;Chambers,JD;vonAndrian,UH;Arfors,KE;Messmer,K;Peter,K
Adhesion molecules on polymorphonuclear leukocytes (PMNL) play an important role in nonspecific defense mechanisms directed at invading microorganisms. When local infection, however, cannot be controlled, a systemic inflammatory response syndrome (SIRS) ensues which may progress to septic shock and multiple organ failure, these being major determinants of the patient’s outcome. In the present study, the expression of β2-integrins and L-selectin on blood PMNL was measured on subsequent days in patients with sepsis (n = 17) and in healthy volunteers (n = 15). β2-Integrins and L-selectin molecules were detected by flow cytometry, using the monoclonal antibodies IB4 (anti-CD 18) and Dreg200 (anti-CD62L), respectively. Adhesion molecules were determined at baseline immediately after blood collection and also 45 min after incubation of cells in vitro at body temperature to allow for spontaneous regulation. In addition, PMNL were activated by receptor-dependent and receptor-independent stimuli to characterize stimulus-specific adhesion molecule expression. In parallel with the measurement of adhesion molecules, severity of sepsis was assessed by the Elebute score. The results demonstrate significant differences in the basal, spontaneous and stimulus-induced expression of adhesion molecules between healthy volunteers, survivors (n = 11) and nonsurvivors (n = 6). Moreover, when survivors and nonsurvivors with severe sepsis (Elebute score > 12) were compared, basal expressions of both β2-integrins and L-selectin were significantly lower in patients who did not survive. Thus, measurement of adhesion molecules on circulating PMNL may be useful to identify septic patients at high risk for lethal outcome.